Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)
Clinical trial NCT01932762 · COMPLETED
Trial details
- NCT number
- NCT01932762
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-12-04
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.